Choom Holdings Inc (CHOOF)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Choom Holdings Net Income (Quarterly): -4.68M for Dec. 31, 2021
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | -4.68M |
September 30, 2021 | 4.024M |
June 30, 2021 | -9.442M |
March 31, 2021 | -2.907M |
December 31, 2020 | -2.580M |
September 30, 2020 | -2.235M |
June 30, 2020 | -4.342M |
March 31, 2020 | -2.958M |
December 31, 2019 | -5.591M |
September 30, 2019 | -2.255M |
June 30, 2019 | -1.184M |
March 31, 2019 | -3.204M |
December 31, 2018 | -70.12M |
September 30, 2018 | -1.968M |
June 30, 2018 | -3.076M |
March 31, 2018 | -0.7213M |
December 31, 2017 | -1.002M |
September 30, 2017 | -0.1261M |
June 30, 2017 | -0.4227M |
March 31, 2017 | -0.0688M |
December 31, 2016 | 0.0085M |
September 30, 2016 | -0.0673M |
June 30, 2016 | -0.2907M |
March 31, 2016 | -0.0594M |
December 31, 2015 | -0.0591M |
Date | Value |
---|---|
September 30, 2015 | -0.0745M |
June 30, 2015 | -0.629M |
March 31, 2015 | -0.0699M |
December 31, 2014 | -0.0884M |
September 30, 2014 | -0.0823M |
June 30, 2014 | -0.8748M |
March 31, 2014 | -0.1347M |
December 31, 2013 | -0.1429M |
September 30, 2013 | -0.1532M |
June 30, 2013 | -0.6103M |
March 31, 2013 | -0.4242M |
December 31, 2012 | -0.2335M |
September 30, 2012 | -0.2756M |
June 30, 2012 | -0.6723M |
March 31, 2012 | -0.8067M |
December 31, 2011 | -0.2909M |
September 30, 2011 | -0.097M |
June 30, 2011 | -0.1584M |
March 31, 2011 | -0.0989M |
December 31, 2010 | -0.088M |
September 30, 2010 | -0.0642M |
June 30, 2010 | -0.0597M |
March 31, 2010 | -0.0289M |
December 31, 2009 | -0.0082M |
September 30, 2009 | -0.033M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-9.442M
Minimum
Jun 2021
4.024M
Maximum
Sep 2021
-3.297M
Average
-2.933M
Median
Net Income (Quarterly) Benchmarks
Biosyntech Inc | -- |
Cotinga Pharmaceuticals Inc | -0.4055M |
Canntab Therapeutics Ltd | -0.3058M |
Acasti Pharma Inc | -2.617M |
Aurinia Pharmaceuticals Inc | 0.722M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 3.344M |
Total Expenses (Quarterly) | 4.252M |
EPS Diluted (Quarterly) | -0.0079 |